humanitarian
Archived signal Translated · Español · 2–5m lag
Medicinas humanas Informe Público Europeo de Evaluación (EPAR): DuoPlavin, clopidogrel, ácido acetilsalicílico, Fecha de autorización: 14/03/2010, Revisión: 32, Estado: Autorizado
Medicamentos para el hombre Informe público europeo de evaluación (EPAR): Zumrad, sasaclimab, Estado: retirada de la solicitud
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
6 reports · 2 sources
EMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): DuoPlavin, clopidogrel, ácido acetilsalicílico, Fecha de autorización: 14/03/2010, Revisión: 32, Estado: AutorizadoEMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): DuoPlavin, clopidogrel, ácido acetilsalicílico, Fecha de autorización: 14/03/2010, Revisión: 32, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources